Testing times

View the article

Topics

Editor's picks

AI drug design

Why the AI drug revolution has yet to deliver

Speed, safety and smarter molecules have yet to translate into better medicines reaching patients. The real breakthrough may come from rethinking what we ask AI to do in the lab, writes Robert Roe

Media Partners